A virtual screening approach for identifying plants with anti H5N1 neuraminidase activity

Journal of Chemical Information and Modeling

Volumn 55, Issue 2, 2015, Pages 308-316

  Ikram, Nur Kusaira Khairul ^a,b   Durrant, Jacob D ^c   Muchtaridi, Muchtaridi ^b   Zalaludin, Ayunni Salihah ^a   Purwitasari, Neny ^b   Mohamed, Nornisah ^b   Rahim, Aisyah Saad Abdul ^b   Lam, Chan Kit ^b   Normi, Yahaya M ^d   Rahman, Noorsaadah Abd ^e   Amaro, Rommie E ^c   Wahab, Habibah A ^a,b  

^a Kemeneterian Sains Teknologi dan Inovasi   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^e UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMISTRY;

EXPERIMENTAL EVALUATION; ISOLATED COMPOUNDS; NATURAL COMPOUNDS; NATURAL PRODUCTS; NEURAMINIDASE INHIBITORS; NEW APPROACHES; PHARMACOLOGICALLY ACTIVE COMPOUNDS; VIRTUAL SCREENING;

CHEMICAL ENGINEERING;

ENZYME INHIBITOR; GARCINONE C; SIALIDASE; XANTHONE DERIVATIVE;

ANTAGONISTS AND INHIBITORS; CHEMICAL DATABASE; CHEMISTRY; ENZYMOLOGY; FALSE POSITIVE RESULT; FRUIT; HIGH THROUGHPUT SCREENING; HUMAN; INFLUENZA A VIRUS (H5N1); INFLUENZA, HUMAN; MALAYSIA; MEDICINAL PLANT; PROCEDURES;

DATABASES, CHEMICAL; ENZYME INHIBITORS; FALSE POSITIVE REACTIONS; FRUIT; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MALAYSIA; NEURAMINIDASE; PLANTS, MEDICINAL; XANTHONES;

EID: 84923319996     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci500405g     Document Type: Article

References (66)

1. Webster, R. G.; Peiris, M.; Chen, H. L.; Guan, Y. H5N1 Outbreaks and Enzootic Influenza Emerging Infect. Dis 2006, 12, 3-8
2. Itzstein, M. V.; Thomson, R. Anti-Influenza Drugs: The Development of Sialidase Inhibitors. In Antiviral Strategies, Handbook of Experimental 111 Pharmacology; Kräusslich, H. G.; Bartenschlager, R., Eds.; Springer-Verlag: Berlin, 2009; p 189.
3. Colman, P. M. Influenza Virus Neuraminidase: Structure, Antibodies, and Inhibitors Protein Sci. 1994, 3, 1687-1696
4. Haskell, T. H.; Peterson, F. E.; Watson, D.; Plessas, N. R.; Culberts, T. Neuraminidase Inhibition and Viral Chemotherapy J. Med. Chem. 1970, 13, 697-704
5. Gong, J. Z.; Xu, W. F.; Zhang, J. Structure and Functions of Influenza Virus Neuraminidase Curr. Med. Chem. 2007, 14, 113-122
6. Gubareva, L. V.; Kaiser, L.; Hayden, F. G. Influenza Virus Neuraminidase Inhibitors Lancet 2000, 355, 827-835
7. Burmeister, W. P.; Ruigrok, R. W. H.; Cusack, S. The 2.2-a Resolution Crystal-Structure of Influenza-B Neuraminidase and Its Complex with Sialic-Acid EMBO J. 1992, 11, 49-56
8. von Itzstein, M. The War against Influenza: Discovery and Development of Sialidase Inhibitors Nat. Rev. Drug Discovery 2007, 6, 967-974
9. De Clercq, E. Antiviral Agents Active against Influenza a Viruses Nat. Rev. Drug Discovery 2006, 5, 1015-1025
10. Coombes, R. U. Stocks up on Antiviral Drug to Tackle Flu Outbreak BMJ 2005, 330, 495-495
11. Jennings, L. C.; Monto, A. S.; Chan, P. K. S.; Szucs, T. D.; Nicholson, K. G. Stockpiling Prepandemic Influenza Vaccines: A New Cornerstone of Pandemic Preparedness Plans Lancet Infect. Dis. 2008, 8, 650-658
12. Kamali, A.; Holodniy, M. Influenza Treatment and Prophylaxis with Neuraminidase Inhibitors: A Review Infect. Drug Resist. 2013, 6, 187-198
13. Dawood, F. S.; Jain, S.; Finelli, L.; Shaw, M. W.; Lindstrom, S.; Garten, R. J.; Gubareva, L. V.; Xu, X. Y.; Bridges, C. B.; Uyeki, T. M. Emergence of a Novel Swine-Origin Influenza a (H1N1) Virus in Humans Novel Swine-Origin Influenza a (H1N1) Virus Investigation Team N. Engl. J. Med. 2009, 360, 2605-2615
14. Meijer, A.; Lackenby, A.; Hungnes, O.; Lina, B.; van der Werf, S.; Schweiger, B.; Opp, M.; Paget, J.; van de Kassteele, J.; Hay, A.; Zambon, M.; Sc, E. I. S. Oseltamivir-Resistant Influenza Virus a (H1N1), Europe, 2007-08 Season Emerging Infect. Dis. 2009, 15, 552-560
15. Moscona, A. Global Transmission of Oseltamivir-Resistant Influenza N. Engl. J. Med. 2009, 360, 953-956
16. de Jong, M. D.; Tran, T. T.; Truong, H. K.; Vo, M. H.; Smith, G. J.; Nguyen, V. C.; Bach, V. C.; Phan, T. Q.; Do, Q. H.; Guan, Y.; Peiris, J. S.; Tran, T. H.; Farrar, J. Oseltamivir Resistance During Treatment of Influenza a (H5N1) Infection N. Engl. J. Med. 2005, 353, 2667-2672
17. Blundell, T. L.; Sibanda, B. L.; Montalvao, R. W.; Brewerton, S.; Chelliah, V.; Worth, C. L.; Harmer, N. J.; Davies, O.; Burke, D. Structural Biology and Bioinformatics in Drug Design: Opportunities and Challenges for Target Identification and Lead Discovery Philos. Trans. R. Soc., B 2006, 361, 413-423
18. Rakers, C.; Schwerdtfeger, S. M.; Mortier, J.; Duwe, S.; Wolff, T.; Wolber, G.; Melzig, M. F. Inhibitory Potency of Flavonoid Derivatives on Influenza Virus Neuraminidase Bioorg. Med. Chem. Lett. 2014, 24, 4312-4317
19. Shan, Y. Y.; Ma, Y.; Wang, M. Y.; Dong, Y. L. Recent Advances in the Structure-Based Design of Neuraminidase Inhibitors as Anti-Influenza Agents Curr. Med. Chem. 2012, 19, 5885-5894
20. Feng, E. G.; Ye, D. J.; Li, J.; Zhang, D. Y.; Wang, J. F.; Zhao, F.; Hilgenfeld, R.; Zheng, M. Y.; Jiang, H. L.; Liu, H. Recent Advances in Neuraminidase Inhibitor Development as Anti-Influenza Drugs ChemMedChem. 2012, 7, 1527-1536
21. Dave, K.; Gandhi, M.; Panchal, H.; Vaidya, M. Revision of Qsar, Docking, and Molecular Modeling Studies of Anti-Influenza Virus a (H1N1) Drugs and Targets: Analysis of Hemagglutinins 3d Structure Curr. Comput.-Aided Drug Des. 2011, 7, 255-262
22. Wang, J. Z.; Ma, C. L.; Wang, J.; Jo, H.; Canturk, B.; Fiorin, G.; Pinto, L. H.; Lamb, R. A.; Klein, M. L.; DeGrado, W. F. Discovery of Novel Dual Inhibitors of the Wild-Type and the Most Prevalent Drug-Resistant Mutant, S31n, of the M2 Proton Channel from Influenza a Virus J. Med. Chem. 2013, 56, 2804-2812
23. Gkeka, P.; Eleftheratos, S.; Kolocouris, A.; Cournia, Z. Free Energy Calculations Reveal the Origin of Binding Preference for Aminoadamantane Blockers of Influenza a/M2tm Pore J. Chem. Theory Comput. 2013, 9, 1272-1281
24. Harvey, A. L. Natural Products in Drug Discovery Drug Discovery Today 2008, 13, 894-901
25. Newman, D. J.; Cragg, G. M. Natural Product Scaffolds as Leads-to Drugs Future Med. Chem. 2009, 1, 1415-1427
26. Nagai, T.; Moriguchi, R.; Suzuki, Y.; Tomimori, T.; Yamada, H. Mode of Action of the Anti-Influenza Virus Activity of Plant Flavonoid, 5,7,4′-Trihydroxy-8-Methoxyflavone, from the Roots of Scutellaria Baicalensis Antiviral Res. 1995, 26, 11-25
27. Grienke, U.; Schmidtke, M.; von Grafenstein, S.; Kirchmair, J.; Liedl, K. R.; Rollinger, J. M. Influenza Neuraminidase: A Druggable Target for Natural Products Nat. Prod. Rep. 2012, 29, 11-36
28. Wahab, H. A.; Asarudin, M. R.; Ahmad, S.; Mohamed, N.; Rahim, A. S. A.; Hamid, S. A.; Osman, H.; Shamsudin, S. Nature Based Drug Discovery (Nadi) & Its Application to Novel Neuraminidase Inhibitors Identification by Virtual Screening, Pharmacophore Modelling and Mapping of Malaysian Medicinal Plants; ICS-UNIDO: Trieste, Italy, 2009.
29. Petersen, F. D.; René, A. Natural Compounds as Drugs; Springer: London, 2008.
30. Ogungbe, I. V.; Setzer, W. N. Comparative Molecular Docking of Antitrypanosomal Natural Products into Multiple Trypanosoma Brucei Drug Targets Molecules 2009, 14, 1513-1536
31. Phosrithong, N.; Ungwitayatorn, J. Molecular Docking Study on Anticancer Activity of Plant-Derived Natural Products Med. Chem. Res. 2010, 19, 817-835
32. Li, C.; Xu, L.; Wolan, D. W.; Wilson, I. A.; Olson, A. J. Virtual Screening of Human 5-Aminoimidazole-4-Carboxamide Ribonucleotide Transformylase against the Nci Diversity Set by Use of Autodock to Identify Novel Nonfolate Inhibitors J. Med. Chem. 2004, 47, 6681-6690
33. Rollinger, J. M.; Steindl, T. M.; Schuster, D.; Kirchmair, J.; Anrain, K.; Ellmerer, E. P.; Langer, T.; Stuppner, H.; Wutzler, P.; Schmidtke, M. Structure-Based Virtual Screening for the Discovery of Natural Inhibitors for Human Rhinovirus Coat Protein J. Med. Chem. 2008, 51, 842-851
34. Lipinski, C. A. Lead- and Drug-Like Compounds: The Rule-of-Five Revolution Drug Discovery Today: Technol. 2004, 1, 337-341
35. Liu, T.; Lin, Y.; Wen, X.; Jorissen, R. N.; Gilson, M. K. Bindingdb: A Web-Accessible Database of Experimentally Determined Protein-Ligand Binding Affinities Nucleic Acids Res. 2007, 35, D198-201
36. Chen, X.; Lin, Y.; Liu, M.; Gilson, M. K. The Binding Database: Data Management and Interface Design Bioinformatics 2002, 18, 130-139
37. Greenwood, J. R.; Calkins, D.; Sullivan, A. P.; Shelley, J. C. Towards the Comprehensive, Rapid, and Accurate Prediction of the Favorable Tautomeric States of Drug-Like Molecules in Aqueous Solution J. Comput.-Aided Mol. Des. 2010, 24, 591-604
38. Shelley, J. C.; Cholleti, A.; Frye, L. L.; Greenwood, J. R.; Timlin, M. R.; Uchimaya, M. Epik: A Software Program for Pk(a) Prediction and Protonation State Generation for Drug-Like Molecules J. Comput.-Aided Mol. Des. 2007, 21, 681-691
39. Jorgensen, W. L.; Maxwell, D. S.; TiradoRives, J. Development and Testing of the Opls All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids J. Am. Chem. Soc. 1996, 118, 11225-11236
40. Kaminski, G. A.; Friesner, R. A.; Tirado-Rives, J.; Jorgensen, W. L. Evaluation and Reparametrization of the Opls-Aa Force Field for Proteins Via Comparison with Accurate Quantum Chemical Calculations on Peptides J. Phys. Chem. B 2001, 105, 6474-6487
41. Sanner, M. F. A Component-Based Software Environment for Visualizing Large Macromolecular Assemblies Structure 2005, 13, 447-462
42. Russell, R. J.; Haire, L. F.; Stevens, D. J.; Collins, P. J.; Lin, Y. P.; Blackburn, G. M.; Hay, A. J.; Gamblin, S. J.; Skehel, J. J. The Structure of H5N1 Avian Influenza Neuraminidase Suggests New Opportunities for Drug Design Nature 2006, 443, 45-49
43. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function J. Comput. Chem. 1998, 19, 1639-1662
44. Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ghio, C.; Alagona, G.; Profeta, S.; Weiner, P. A New Force Field for Molecular Mechanical Simulation of Nucleic Acids and Proteins J. Am. Chem. Soc. 1984, 106, 765-784
45. Gasteiger, J.; Marsili, M. Iterative Partial Equalization of Orbital Electronegativity - a Rapid Access to Atomic Charges Tetrahedron 1980, 36, 3219-3228
46. Morris, G. M.; Goodsell, D. S.; Huey, R.; Hart, W. E.; Halliday, S.; Belew, R.; Olson, A. J. Autodock: Automated Docking of Flexible Ligands to Receptors, version 3.0.5; Scripps Research Institute: San Diego, California, 2001.
47. Potier, M.; Mameli, L.; Belisle, M.; Dallaire, L.; Melancon, S. B. Fluorometric Assay of Neuraminidase with a Sodium (4-Methylumbelliferyl-Alpha-D-N-Acetylneuraminate) Substrate Anal. Biochem. 1979, 94, 287-296
48. Feng, B. Y.; Shoichet, B. K. A Detergent-Based Assay for the Detection of Promiscuous Inhibitors Nat. Protoc. 2006, 1, 550-553
49. Ryu, H. W.; Curtis-Long, M. J.; Jung, S.; Jin, Y. M.; Cho, J. K.; Ryu, Y. B.; Lee, W. S.; Park, K. H. Xanthones with Neuraminidase Inhibitory Activity from the Seedcases of Garcinia Mangostana Bioorg. Med. Chem. 2010, 18, 6258-6264
50. Obolskiy, D.; Pischel, I.; Siriwatanametanon, N.; Heinrich, M.; Garcinia Mangostana, L. A Phytochemical and Pharmacological Review Phytother. Res. 2009, 23, 1047-1065
51. Pedraza-Chaverri, J.; Cardenas-Rodriguez, N.; Orozco-Ibarra, M.; Perez-Rojas, J. M. Medicinal Properties of Mangosteen (Garcinia Mangostana) Food Chem. Toxicol. 2008, 46, 3227-3239
52. Lian, G. E. C.; Rahmani, M. B. Available from http://km.upm.edu.my/kmportalweb/infox/assetDetailAction.action?execute=view&assetId=000001421&actionFlg=alllist.
53. Ryu, Y. B.; Curtis-Long, M. J.; Lee, J. W.; Kim, J. H.; Kim, J. Y.; Kang, K. Y.; Lee, W. S.; Park, K. H. Characteristic of Neuraminidase Inhibitory Xanthones from Cudrania Tricuspidata Bioorg. Med. Chem. 2009, 17, 2744-2750
54. Feng, B. Y.; Simeonov, A.; Jadhav, A.; Babaoglu, K.; Inglese, J.; Shoichet, B. K.; Austin, C. P. A High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library J. Med. Chem. 2007, 50, 2385-2390
55. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy J. Med. Chem. 2004, 47, 1739-1749
56. Halgren, T. A.; Murphy, R. B.; Friesner, R. A.; Beard, H. S.; Frye, L. L.; Pollard, W. T.; Banks, J. L. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening J. Med. Chem. 2004, 47, 1750-1759
57. Durrant, J. D.; McCammon, J. A. Binana: A Novel Algorithm for Ligand-Binding Characterization J. Mol. Graphics Modell. 2011, 29, 888-893
58. Stierand, K.; Maass, P. C.; Rarey, M. Molecular Complexes at a Glance: Automated Generation of Two-Dimensional Complex Diagrams Bioinformatics 2006, 22, 1710-1716
59. Stierand, K.; Rarey, M. Drawing the Pdb: Protein-Ligand Complexes in Two Dimensions Acs. Med. Chem. Lett. 2010, 1, 540-545
60. Humphrey, W.; Dalke, A.; Schulten, K. Vmd: Visual Molecular Dynamics J. Mol. Graphics 1996, 14, 33-38
61. Amaro, R. E.; Swift, R. V.; Votapka, L.; Li, W. W.; Walker, R. C.; Bush, R. M. Mechanism of 150-Cavity Formation in Influenza Neuraminidase Nat. Commun. 2011, 2, 388
62. Wu, Y.; Qin, G. R.; Gao, F.; Liu, Y.; Vavricka, C. J.; Qi, J. X.; Jiang, H. L.; Yu, K. Q.; Gao, G. F. Induced Opening of Influenza Virus Neuraminidase N2 150-Loop Suggests an Important Role in Inhibitor Binding Sci. Rep. 2013, 3, 1551
63. Sharma, A.; Tendulkar, A. V.; Wangikar, P. P. Drug Discovery against H1N1 Virus (Influenza a Virus) Via Computational Virtual Screening Approach Med. Chem. Res. 2011, 20, 1445-1449
64. Saha, R. K.; Takahashi, T.; Suzuki, T. Glucosyl Hesperidin Prevents Influenza a Virus Replication in Vitro by Inhibition of Viral Sialidase Biol. Pharm. Bull. 2009, 32, 1188-1192
65. Wang, X. Y.; Jia, W.; Zhao, A. H.; Wang, X. R. Anti-Influenza Agents from Plants and Traditional Chinese Medicine Phytother. Res. 2006, 20, 335-341
66. Warren, G. L.; Andrews, C. W.; Capelli, A. M.; Clarke, B.; LaLonde, J.; Lambert, M. H.; Lindvall, M.; Nevins, N.; Semus, S. F.; Senger, S.; Tedesco, G.; Wall, I. D.; Woolven, J. M.; Peishoff, C. E.; Head, M. S. A Critical Assessment of Docking Programs and Scoring Functions J. Med. Chem. 2006, 49, 5912-5931